Related Experiment Video
Updated: Dec 14, 2025
09:54
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
6.0K
Die another way: Ferroptosis drives tuberculosis pathology
Etienne Meunier1, Olivier Neyrolles2
1Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique, Université Paul Sabatier, Toulouse, France.
The Journal of Experimental Medicine
|February 22, 2019
Summary
Ferroptosis, a form of regulated cell death, harms the host during Mycobacterium tuberculosis infection. This discovery offers new avenues for developing host-directed tuberculosis therapies.
Area of Science:
- Immunology
- Cell Biology
- Infectious Diseases
Background:
- Tuberculosis (TB) is a major global health challenge caused by Mycobacterium tuberculosis.
- Regulated cell death pathways are crucial in host-pathogen interactions.
- Ferroptosis, a distinct form of regulated cell death, has recently been identified.
Purpose of the Study:
- To investigate the role of ferroptosis in the host response to Mycobacterium tuberculosis infection.
- To determine whether ferroptosis is beneficial or detrimental to the host during TB.
Main Methods:
- The study utilized a mouse model of Mycobacterium tuberculosis infection.
- Researchers analyzed host cell death mechanisms, specifically focusing on ferroptosis.
- Gene expression and cellular markers associated with ferroptosis were assessed.
Main Results:
- The study provides the first evidence that ferroptosis is detrimental to the host during Mycobacterium tuberculosis infection.
- Increased ferroptosis was observed in infected host tissues.
- Inhibition of ferroptosis showed potential benefits for the host.
Conclusions:
- Ferroptosis represents a harmful host response during Mycobacterium tuberculosis infection.
- Targeting ferroptosis could be a novel strategy for host-directed therapies against TB.
- Further research into ferroptosis modulation is warranted for TB treatment development.
